Company: SCLXW
Filing Date: 2025-12-29
Form Type: 424B3
Source: 0001193125-25-335429
Chunk: 440

Company: Scilex Holding Co
Filing Date: 2025-12-29
Form: 424B3
Chunk 440
---
ramed Note and any Additional Notes are paid in full. The business address of SCLX Stock Acquisition JV LLC is 960 San Antonio Road, Palo Alto, CA 94303.                                                               |

| (10) | Represents 833,473 shares underlying certain warrants to purchase Common Stock, with an exercise price of $0.01                                                                                                                                         
 per share, held by Oramed exercisable within 60 days of December 5, 2025. Such warrants held by Oramed are subject to a 9.99% beneficial ownership limitation and the number of shares of Common Stock set forth in the table above give effect to such 
 limitation. The foregoing ownership information for Oramed is based on information supplied by Oramed in a statement on Schedule 13G/A filed with the SEC on November 14, 2025 that reports its sole voting power and sole dispositive power. The       
 business address of Oramed Pharmaceuticals Inc. is 1185 Avenue of the Americas, Third Floor, New York, NY 10036.                                                                                                                                        |

| (11) | Consists of 517,425 shares of Common Stock held directly. This excludes an aggregate of 1,832,418 shares                                                                                                                                             
 underlying certain warrants to purchase Common Stock held by the Selling Stockholder comprised of: (i) 475,824 shares underlying the December 2024 RDO Common Warrants and (ii) 1,356,594 shares underlying the November 2025 Investor               
 Warrants. The warrants are subject to a beneficial ownership limitation of 4.99%, and the number of shares of Common Stock set forth in the table above gives effect to such limitation. The securities are directly held by Master Fund, and may be 
 deemed to be beneficially owned by: (i) Armistice Capital as the investment manager of the Master Fund; and (ii) Steven Boyd, as the Managing Member of Armistice Capital. The address of Armistice Capital Master Fund Ltd. is c/o Armistice        
 Capital, LLC, 510 Madison Avenue, 7th Floor, New York, NY 10022.                                                                                                                                                                                     |

286

MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES The following is a discussion of certain material U.S. federal income tax considerations generally applicable to the purchase, ownership and disposition of our Common Stock and Exchange Warrants, which we refer to collectively as our “securities.” This discussion is based on provisions of the Code, the Treasury Regulations